Analyst Ratings for Myriad Genetics (MYGN)

MYGN Rating Summary

MYGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $33.00 (+30%) * Over Last 12-Mos
Rating Score: 1.9 / 10   Percentile Rank: 13%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/26/2019 BofA Securities Derik de Bruin Downgrade Underperform
(Neutral)
N/A
(N/A)
29.93
(25.39)
-15.17% Details
8/14/2019 Barclays
» Updated 11/5/2019
Jack Meehan Downgrade Underweight
(Equalweight)
18.00
(22.00)
44.55
(25.39)
-43.01% Details
Like MYGN Ratings? Also take a look at ILMN, LH, AZN, CERC

MYGN Ratings News